| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 10546 | 2013 |
| Genomic classification and prognosis in acute myeloid leukemia E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ... New England Journal of Medicine 374 (23), 2209-2221, 2016 | 4374 | 2016 |
| Heterogeneity of genomic evolution and mutational profiles in multiple myeloma N Bolli, H Avet-Loiseau, DC Wedge, P Van Loo, LB Alexandrov, ... Nature communications 5 (1), 2997, 2014 | 1020 | 2014 |
| A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, F Davies, ... Leukemia 33 (1), 159-170, 2019 | 469 | 2019 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 460 | 2014 |
| Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, FE Davies, ... Blood, The Journal of the American Society of Hematology 132 (6), 587-597, 2018 | 459 | 2018 |
| Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ... elife 3, e02935, 2014 | 428 | 2014 |
| Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature genetics 52 (3), 306-319, 2020 | 385 | 2020 |
| Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML B Falini, N Bolli, J Shan, MP Martelli, A Liso, A Pucciarini, B Bigerna, ... Blood 107 (11), 4514-4523, 2006 | 380 | 2006 |
| Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer S Nik-Zainal, DC Wedge, LB Alexandrov, M Petljak, AP Butler, N Bolli, ... Nature genetics 46 (5), 487-491, 2014 | 319 | 2014 |
| Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? B Falini, MP Martelli, N Bolli, P Sportoletti, A Liso, E Tiacci, T Haferlach Blood, The Journal of the American Society of Hematology 117 (4), 1109-1120, 2011 | 311 | 2011 |
| Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications B Falini, N Bolli, A Liso, MP Martelli, R Mannucci, S Pileri, I Nicoletti Leukemia 23 (10), 1731-1743, 2009 | 306 | 2009 |
| Precision oncology for acute myeloid leukemia using a knowledge bank approach M Gerstung, E Papaemmanuil, I Martincorena, L Bullinger, VI Gaidzik, ... Nature genetics 49 (3), 332-340, 2017 | 304 | 2017 |
| Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias B Falini, I Nicoletti, N Bolli, MP Martelli, A Liso, P Gorello, F Mandelli, ... haematologica 92 (4), 519-532, 2007 | 285 | 2007 |
| Genomic landscape and chronological reconstruction of driver events in multiple myeloma F Maura, N Bolli, N Angelopoulos, KJ Dawson, D Leongamornlert, ... Nature communications 10 (1), 3835, 2019 | 283 | 2019 |
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia B Falini, MP Martelli, N Bolli, R Bonasso, E Ghia, MT Pallotta, D Diverio, ... Blood 108 (6), 1999-2005, 2006 | 228 | 2006 |
| Australian Pancreatic Cancer Genome I LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ... Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013 | 221 | 2013 |
| Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin H Quentmeier, MP Martelli, WG Dirks, N Bolli, A Liso, RAF MacLeod, ... Leukemia 19 (10), 1760-1767, 2005 | 212 | 2005 |
| Genomic patterns of progression in smoldering multiple myeloma N Bolli, F Maura, S Minvielle, D Gloznik, R Szalat, A Fullam, ... Nature communications 9 (1), 3363, 2018 | 208 | 2018 |
| Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups N Bolli, G Biancon, M Moarii, S Gimondi, Y Li, C de Philippis, F Maura, ... Leukemia 32 (12), 2604-2616, 2018 | 204 | 2018 |
